Genymed Therapeutics Private Limited

Genymed Therapeutics Private Limited - chemicals and materials in Bhubaneswar, Odisha, India. FY 2026 financials & compliance.
CIN U51909OR2018PTC029941 Incorporated 27 November 2018 ROC Cuttack HQ Bhubaneswar, Odisha, India
Active Private Limited Company chemicals and materials
Data last updated
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2023
Balance sheet date
Last AGM
30 Sep 2023
Annual general meeting
Company status
Active
MCA master data

About Genymed Therapeutics Private Limited

Data last updated:

Genymed Therapeutics Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 27 November 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2018PTC029941. Its GSTIN is 21AAHCG5661M1ZF (Odisha).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Debasish Das and Ruchi Rangina Das.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot – 4256 Near Geeta Khetra Pandra Ggp Colony Rasulgarh, Bhubaneswar, Odisha, India – 751025.

For more details, the company can be reached via its website genymedtherapeutics.in.

Company details

CIN U51909OR2018PTC029941
Registration Number 029941
Incorporation Date 27 November 2018
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023

Contact details

Genymed Therapeutics Private Limited's registered office is in Bhubaneswar, Odisha. Its website is genymedtherapeutics.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot – 4256 Near Geeta Khetra Pandra Ggp Colony Rasulgarh, Bhubaneswar, Odisha, India – 751025
  • Industry
    Chemicals and Materials, Chemical Distribution & Retail

To see the full contact details of Genymed Therapeutics Private Limited, buy the company report.

Comprehensive company report
Genymed Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Genymed Therapeutics is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Genymed Therapeutics Private Limited, buy the company report.

Financials of Genymed Therapeutics Private Limited

FY 2023 filings available

Financial Statement Summary

MetricsFY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Genymed Therapeutics Private Limited, buy the company report.

Board of directors of Genymed Therapeutics Private Limited

Genymed Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Debasish DasDirector27 Nov 20187 Years 11 MonthsCurrent
Ruchi Rangina DasDirector02 Jan 20206 Years 10 MonthsCurrent

Auditor

Genymed Therapeutics Private Limited is audited by K SWAIN & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
K SWAIN & COFY 2020323847E

Shareholding

The shareholding of Genymed Therapeutics Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Genymed Therapeutics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Genymed Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Genymed Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
21AAHCG5661M1ZFOdishaActive05 Apr 2019

To see the full GST registrations and return filing status of Genymed Therapeutics Private Limited, buy the company report.

Recent activity

Genymed Therapeutics Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Kuna Chandra Das ceased to be Director on 02 Jan 2020.

AGM
Genymed Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Genymed Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
Ceased
Kuna Chandra Das ceased to be Director.
Appointed
Ruchi Rangina Das was appointed as Director.
Ceased
Bauri Bandhu Pradhan ceased to be Director.
Appointed
Debasish Das was appointed as Director.
Incorporation
27 Nov 2018
Genymed Therapeutics Private Limited was registered on 27 Nov 2018 with Roc Cuttack & aged 7 years 11 months as per MCA records.

Frequently asked questions

Genymed Therapeutics is an active private limited company based in Bhubaneswar, Odisha, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 27 November 2018 (8+ years old) and is registered under CIN U51909OR2018PTC029941.

Genymed Therapeutics has 2 current directors:

The latest financial statements of Genymed Therapeutics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Genymed Therapeutics is 21AAHCG5661M1ZF, registered in Odisha.

The CIN (Corporate Identification Number) of Genymed Therapeutics is U51909OR2018PTC029941. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Genymed Therapeutics was incorporated on 27 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Cuttack.

Kuna Chandra Das ceased to be Director on 02 Jan 2020. Ruchi Rangina Das was appointed as Director on 02 Jan 2020. Bauri Bandhu Pradhan ceased to be Director on 06 Nov 2019. Genymed Therapeutics has 4 board changes on record in total.

Genymed Therapeutics can be reached through the website genymedtherapeutics.in. Its registered office is in Bhubaneswar, Odisha, India.

The registered office of Genymed Therapeutics is at Plot – 4256 Near Geeta Khetra Pandra Ggp Colony Rasulgarh, Bhubaneswar, Odisha, India – 751025.

Genymed Therapeutics operates in the chemicals and materials industry, in the chemical distribution and retail segment.